Monitoring Patients on Menin Inhibitors

Zepcan establishes the monitoring timeline pharmacists need to implement, including QTc surveillance intervals, laboratory testing schedules, and symptom escalation protocols. She clarifies the thresholds that require immediate prescriber contact versus routine documentation and explains how pharmacists shift from passive observers to active toxicity managers in this patient population.